Camurus AB (CAMRF)
63.30
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Camurus EPS Diluted (Quarterly) : 0.263 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -0.417 |
| Swedencare AB | 0.0121 |
| Moberg Pharma AB | -0.003 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.73M |
| Revenue (Quarterly) | 58.32M |
| Total Expenses (Quarterly) | 42.59M |
| Enterprise Value | 3.372B |
| Gross Profit Margin (Quarterly) | 91.74% |
| Profit Margin (Quarterly) | 26.98% |
| Earnings Yield | 1.89% |
| Operating Earnings Yield | 2.32% |
| Normalized Earnings Yield | 1.894 |